Allen & Overy Reps Novartis In $5B 3-Part Bond Issue
Swiss pharmaceutical giant Novartis AG has revealed plans to launch a $5 billion bond market transaction in three increments, saying the proceeds would be primarily funneled toward its pending $28.1 billion...To view the full article, register now.
Already a subscriber? Click here to view full article